Blossom Damania
Blossom Damania is an expert in Infectiology at UNC Lineberger Comprehensive Cancer Center (United States). Blossom Damania has authored 245 publications, the most recent in 2026. SLR score: 971 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Oncology - Hematology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 245
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Modulation of DNA Damage by Epstein-Barr Virus (EBV). PMID 42797866 — cells, genes, virology, neoplasms, herpesviridae, herpesvirus 4, human, oncogenic viruses, genomic instability, viruses, dna damage | Viruses | 2026 | 0 |
| Emerging Biomarkers and Biotherapies for EBV-Associated Cancers. PMID 42797811 — virology, neoplasms, biomarkers, immunotherapy, herpesvirus 4, human, viruses, immune system, biological therapy, infections | Viruses | 2026 | 0 |
| KSHV promotes leukocyte adhesion and transendothelial migration via induction of VCAM1. PMID 42708602 — cytokines, cells, vascular cell adhesion molecule-1, tissue adhesions, growth, cell adhesion molecules, neoplasms, sarcoma, cell adhesion, viruses, leukocytes, endothelial cells, herpesvirus 8, human | mBio | 2026 | 0 |
| VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response. PMID 42507754 — cells, vaccinia, viruses, immunity, interferon type i, integration host factors, herpesvirus 8, human, immunity, innate, antiviral agents, infections, virus diseases | PLoS Pathog | 2026 | 0 |
| NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma. PMID 42133805 — cells, oncogene proteins, lymphocytes, hodgkin disease, pharmaceutical preparations, lymphoma, neoplasms, herpesvirus 4, human, viruses, lymphoma, non-hodgkin, therapeutics, infections, drug resistance | Proc Natl Acad Sci U S A | 2026 | 0 |
LeadR Networks
Main global connection map